
Are Weight-Loss Drugs the Answer for Fatty Liver Disease?
Treatment of metabolic dysfunction-associated steatohepatitis (MASH) may soon be added to the growing list of indications for GLP-1 agonists such as semaglutide (sold as Ozempic and Wegovy). Some experts, however, stress that liver-directed medications are …